GNS Healthcare
 | |
| Type | Private (subsidiary of Via Science) |
|---|---|
| Founded | Ithaca, New York, USA (2000) |
| Founder | Colin Hill (CEO) Iya Khalil |
| Headquarters | , USA |
| Website | https://www.aitiabio.com/ |
Aitia (f.k.a GNS Healthcare) is a biosimulation company based in Somerville, MA.
History
The company was founded in 2000 as Gene Network Sciences (GNS) by Colin Hill and Iya Khalil, who studied physics at Cornell University. Its early work focused on computational biology models of interactions among genes and proteins in cells, with a focus on cancer drug discovery.[1]
Aitia was formed as a subsidiary of GNS in 2010 to apply the data analytic methods the company had developed to the healthcare provider, health insurance, pharmacy benefit management and health informatics industries.[2]
References
- ↑ Friedlander, Blaine (October 21, 2002). "Gene Network Sciences, company started and funded by Cornell students, gets $2 million federal grant for cancer research". Cornell Chronicle.
- ↑ McBride, Ryan (27 April 2010). "Gene Network Sciences Using Supercomputing to Match Patients with a Drug That Works". Xconomy.
Further reading
- Kolakowski, Nick (September 26, 2012) "GNS Healthcare, Aetna Team on Analytics to Combat Metabolic Syndrome"[link removed]. "Slashdot".
- Cambia Health Solutions (April 18, 2012) "Cambia Health Solutions Announces Investment in GNS Healthcare"[link removed]. (Press release).
- Miller, Katherine (January 2, 2012) "Big Data Analytics In Biomedical Research" Archived 2012-05-24 at the Wayback Machine. Biomedical Computation Review.
- Council on Competitiveness (June 30, 2011) "Council on Competitiveness Showcases Power of High Performance Computing in Case Study with GNS Healthcare" Archived 2011-12-02 at the Wayback Machine (Press release).